Search the Newsreel

Smith Douglas Homes (NYSE:SDHC) Shares Gap Down - What's Next?

Allison Schedules Second Quarter 2026 Earnings Conference Call

Allison Transmission Holdings Inc. announced its second quarter 2026 financial results conference call will take place on Monday, August 3, 2026, at 5:00 p.m. EDT. Executives will discuss the company's financial performance, with the news release issued post-market on the same day. A live …

GSK plc Stock (GSK) Closed Down by 3.17% on Jul 20: Facts Behind the Movement

GSK plc (GSK) stock fell by 3.17% on July 20, driven by renewed concerns over the Zantac litigation, heightened competition in vaccine markets, rising R&D costs, and broader regulatory scrutiny in the healthcare sector. Technical indicators suggest potential selling pressure, while analysts have adjusted …

Allison to release Q2 results after market close Aug. 3

Allison Transmission (NYSE: ALSN) is scheduled to hold its second-quarter 2026 earnings conference call on Monday, August 3, 2026, at 5:00 p.m. EDT. The company will release its financial results after market close on the same day. Investors can access the call via phone …

Smith & Nephew stock advances on earnings and margin focus

Smith & Nephew's stock movement is being evaluated based on its latest earnings, margin, and cash flow performance. The company, a global medical technology group, focuses on orthopedics, sports medicine, and wound care. Investors are primarily looking at sales growth, margin development, and free …

EMA reviews GSK (NYSE: GSK) plan for 1-dose Bexsero meningitis B booster

GSK has announced that the European Medicines Agency (EMA) has accepted its submission to update the label for Bexsero to include a single-dose booster for individuals aged 10 years and older who were previously vaccinated. This proposed booster aims to help reduce the burden …

Lobbying Update: $120,000 of SMITHFIELD FOODS INC. lobbying was just disclosed

A recent Lobbying Disclosure Act filing revealed that SMITHFIELD FOODS INC. engaged in $120,000 worth of lobbying during Q2 2026. The lobbying efforts focused on promoting science-based animal welfare, Farm Bill reauthorization, and issues regarding foreign ownership of agricultural land. Insider trading data shows …

GSK falls Monday, underperforms market

Shares of GSK PLC (GSK) fell on Monday, sliding 1.80% to £18.82, underperforming the broader market as the FTSE 100 Index also declined. The company's stock closed significantly below its 52-week high.

A.O. Smith stock holds near recent highs as earnings and water-heating demand support valuation

A.O. Smith stock is trading near its 52-week highs, driven by strong demand for water-heating solutions and consistent earnings growth. The company's strategic mix of residential and commercial markets, coupled with its focus on energy-efficient products and disciplined capital allocation, provides resilience and supports …

Smithfield Foods (SFD) Q1 2026 earnings summary

Smithfield Foods (SFD) reported record first-quarter results for 2026, with net sales reaching $3.8 billion, a 0.8% increase year-over-year, and adjusted operating profit rising 4% to $339 million. The company announced the acquisition of Nathan's Famous, expected to close in H2 2026, and provided …

GSK: EMA Accepts Filing For Bexsero Single-Dose Booster In Adolescents

(RTTNews) - GSK plc (GSK) announced that the European Medicines Agency (EMA) has accepted its submission to update the label for Bexsero, aiming to include a single-dose booster for individuals aged 10 years and older who were previously vaccinated in infancy. Invasive meningococcal disease …

Smith & Nephew stock holds steady as 2025 revenue and margin guide frame the next update

Smith & Nephew's stock performance is currently framed by its 2025 financial guidance, which includes an expected underlying revenue growth of 4.0% to 5.0%, a trading profit margin of around 19.5%, and cash conversion of approximately 90%. These figures serve as key benchmarks for …

Avoiding Lag: Real-Time Signals in (GSK) Movement

This article provides real-time signal analysis for GSK, highlighting weak near-term sentiment but strong long-term projections. It offers three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also includes multi-timeframe signal strengths, support, and resistance levels …

SMID Stock Price and Chart — NASDAQ:SMID

This article provides an overview of Smith-Midland Corporation (NASDAQ: SMID) stock, including its current price, key financial stats, and performance history. It also features technical analysis indicators, seasonal trends, and a list of ETFs holding SMID stock. The company specializes in manufacturing precast concrete …

JBG SMITH Announces Date of Second Quarter 2026 Results

JBG SMITH (NYSE: JBGS) announced it will release its second-quarter 2026 financial results after the close of trading on August 4, 2026. The earnings release and investor package will be available on the Investor Relations section of the company's website. JBG SMITH is a …

Smithfield Foods (SFD) Could Be 18% Undervalued Following Its Recent Share Price Rise

Smithfield Foods (SFD) has seen recent stock price gains, including a 0.6% rise over the last day and a 4.5% increase in the past week, yet it may still be undervalued by 18%. The company's shares are currently trading at $25.77, below a fair …

Analysts Offer Insights on Real Estate Companies: Digital Realty (DLR), AGNC Investment (AGNC) and Smith Douglas Homes Corp. Class A (SDHC)

Wells Fargo analysts have provided insights on several real estate companies. Eric Luebchow maintained a Buy rating on Digital Realty (DLR) with a $220 price target, Donald Fandetti reiterated a Buy rating on AGNC Investment (AGNC) with a $12 price target, and Sam Reid …

Smith & Nephew stock holds steady as Q1 2026 growth and margin improvement underpin outlook

Smith & Nephew's stock is supported by robust Q1 2026 revenue growth and improving trading profit margins, driven by stronger Orthopaedics demand and disciplined cost control. The company reported increased revenue from $5.5 billion in fiscal 2023 to over $5.8 billion in 2025, with …

A.O. Smith stock supported by margin gains and cash returns after strong 2023 results

A.O. Smith Corp. (NYSE: AOS) reported higher profitability and increased cash returns to shareholders in 2023, with diluted EPS rising by a mid-teens percentage rate. Despite a slight decline in full-year sales, driven by weaker residential demand, the company saw improved operating margins due …

Smith & Nephew (SNN) Slips 2.6% as Market Digests Headwinds - Pre-Earnings Momentum

GSK (GSK) Stock Price, News & Analysis $GSK

GSK (GlaxoSmithKline plc) is a London-headquartered pharmaceutical company focused on prescription medicines, vaccines, and specialty treatments. The company's stock currently has a "Hold" consensus rating from analysts, with a price target of $53.00, approximately 5.5% higher than its current trading price. Recent news indicates …

GSK plc (NYSE: GSK) plans Deloitte re-appointment as external auditor from 2028

GSK plc announced its decision to re-appoint Deloitte LLP as its external auditor starting from the financial year ending December 31, 2028, following a competitive tender process. As a Public Interest Entity, GSK is required to tender its statutory audit every 10 years and …

Allison Transmission (NYSE:ALSN) Given New $130.00 Price Target at Morgan Stanley

Morgan Stanley has raised its price target for Allison Transmission (NYSE:ALSN) to $130.00 from $126.00, maintaining an "equal weight" rating, suggesting a potential upside of 13.87%. This update comes after Allison Transmission reported strong quarterly results, with EPS of $2.57 and revenue of $1.41 …

A.O. Smith Corp. stock underperforms Friday when compared to competitors

Shares of A.O. Smith Corp. (AOS) fell 2.78% on Friday, closing at $58.85. This performance lagged behind the broader market, with both the S&P 500 Index (SPX) and the Dow Jones Industrial Average (DJIA) also experiencing declines. The company's stock is now 28.11% below …

A. O. Smith stock trades near highs as water heating demand supports earnings

A. O. Smith Corp. (NYSE: AOS) stock is trading near 52-week highs, driven by strong demand for residential and commercial water heating and treatment systems. The company reported a 5.9% increase in Q1 2024 revenue to $978.1 million and a 16% rise in net …

GSK (NYSE: GSK) halts camlipixant cough drug after Phase III data

GSK has decided to halt further development of camlipixant for refractory chronic cough (RCC) after mixed results from its CALM-1 and CALM-2 Phase III trials. While the 50mg dose achieved the primary endpoint of reducing cough frequency in CALM-1, it failed to meet statistical …

Smith & Nephew stock trades steadily as recent earnings highlight margin focus

Smith & Nephew's recent financial results indicate steady revenue growth but also highlight ongoing margin pressures, driven by cost inflation and R&D investments. The company, which specializes in orthopedics, sports medicine, and advanced wound care, reported approximately $5.5 billion in annual revenue with incremental …

Smith & Wesson Brands (NASDAQ:SWBI) Stock Price Up 2.1% - Here's What Happened

Smith & Wesson Brands (NASDAQ:SWBI) saw its stock price increase by 2.1% on Thursday, closing at $15.25. This rise follows strong recent earnings where the company beat analyst expectations, reporting $0.36 per share on revenues of $178.39 million, a 26.7% year-over-year increase. Analysts have …

GSK plc (NYSE: GSK) insiders add ADSs through dividend reinvestment

GSK plc reported that several senior leaders and non-executive directors acquired American Depositary Shares (ADS) between July 10 and July 14, 2026. These acquisitions were a result of the automatic reinvestment of cash dividends paid to shareholders on July 9, 2026, with ADS prices …

Former Smith+Nephew Global Orthopaedics President Craig Gaffin Joins MedEdge Holdings as Partner

Craig Gaffin, former president of Smith+Nephew's global orthopaedics business, has joined MedEdge Holdings as a partner. MedEdge, founded in 2025, focuses on acquiring, building, and commercializing innovative surgical technology companies and expanding a nationwide commercial infrastructure. Gaffin's extensive commercial leadership experience aims to help …

Smith+Nephew unveils Lynx Coblation Laryngeal Wand for laryngology

Smith+Nephew has launched its Lynx Coblation Laryngeal Wand, a device designed for ENT surgeons performing laryngology procedures. The wand offers flexibility, an extended working length, and malleability, allowing for fine dissection and mass debulking at lower temperatures than traditional lasers. It facilitates radial incisions …

Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons

Smith+Nephew has launched its new LYNX™ COBLATION™ Laryngeal Wand, a multi-purpose surgical tool designed specifically for ENT surgeons. This wand offers improved efficiency, better access to target anatomy, and a malleable shaft, leveraging Smith+Nephew’s COBLATION Technology for precise tissue removal at low temperatures. Surgeons …

Allison Transmission Holdings, Inc. (NYSE:ALSN) Given Average Rating of "Moderate Buy" by Brokerages

Allison Transmission Holdings, Inc. (NYSE:ALSN) has received a consensus "Moderate Buy" rating from eight brokerages, with an average 12-month price target of $130.50. The company recently exceeded earnings expectations, reporting an EPS of $2.57 and revenue of $1.41 billion, an 83.6% increase year over …

Smith & Nephew stock holds steady as medical technology portfolio supports long-term growth

Smith & Nephew (GB0009223206) is a global medical technology company focusing on orthopedics, sports medicine, and advanced wound management. Its diversified portfolio, including established implant franchises and minimally invasive technologies, supports long-term growth and stable cash flows. The company's products are sold worldwide to …

Smith & Nephew SNATS, Inc. (SNN): Investor Outlook on a Healthcare Giant with 10.98% Upside Potential

Smith & Nephew SNATS, Inc. (NYSE: SNN) is presented as a compelling investment opportunity in the healthcare sector, offering a 10.98% upside potential based on analyst targets. The company, known for orthopaedics, sports medicine, and advanced wound management, shows robust revenue growth and a …

Smith & Wesson Brands (SWBI) Stock Forum and Discussion

This article provides a platform for discussion and a stock forum specifically for Smith & Wesson Brands (SWBI). It allows investors and interested parties to engage in conversations about the company's stock performance, news, and future outlook. The content is primarily an interactive forum.